Ashraf Badros: Clinical Trials

1 trial sponsored by Ashraf Badros, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1
Phase 21Terminated 1

Follow Ashraf Badros: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
1454GCC: Anti-PD-1 (MK-3475) and IMiD (Pomalidomide) Combination Immunotherapy in Relapsed/Refractory Multiple Myeloma
MK-3475, Pomalidomide, Dexamethasone - Multiple Myeloma
Phase 1 / Phase 2TerminatedAshraf Badros482014-12-302019-11-05

Conditions studied

Multiple Myeloma (1)  ·  Recurrence (1)

Interventions

Calcium Dobesilate (1)  ·  Dexamethasone (1)  ·  pembrolizumab (1)  ·  pomalidomide (1)

Countries

United States (1)

Top investigators

Ashraf Z Badros, M.B.,Ch.B (1)

Results publications

PMID 28461396